The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Vismodegib in the treatment of patients with metastatic basal cell carcinoma (mBCC) and distant metastases: Survival in the pivotal phase II and phase I studies.
Karl D. Lewis
Consultant or Advisory Role - Roche/Genentech
Honoraria - Roche/Genentech
Research Funding - Roche/Genentech
Aleksandar Sekulic
Consultant or Advisory Role - Roche/Genentech
Axel Hauschild
Consultant or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Eisai; GlaxoSmithKline; MedImmune; MELA Sciences; Merck Serono; Merck Sharp & Dohme; Novartis; OncoSec; Roche
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Eisai; GlaxoSmithKline; MedImmune; MELA Sciences; Merck Serono; Merck Sharp & Dohme; Novartis; OncoSec; Roche
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; Eisai; GlaxoSmithKline; MedImmune; MELA Sciences; Merck Serono; Merck Sharp & Dohme; Novartis; OncoSec; Roche
Michael Robert Migden
Consultant or Advisory Role - Genentech
Research Funding - Genentech
Anthony E. Oro
No relevant relationships to disclose
Patricia LoRusso
No relevant relationships to disclose
Charles M. Rudin
Consultant or Advisory Role - AVEO; Celgene; Merck
Luc Dirix
No relevant relationships to disclose
James A. Solomon
Consultant or Advisory Role - Genentech
Research Funding - Genentech
John D. Hainsworth
Research Funding - Genentech
Sarah Williams
Employment or Leadership Position - Roche Products Ltd
Jeannie Hou
Employment or Leadership Position - Genentech
Stock Ownership - Genentech
Daniel D. Von Hoff
Consultant or Advisory Role - Roche/Genentech
Honoraria - Roche/Genentech
Research Funding - Roche